Time patterns of changes in biomarkers, symptoms and histopathology during pelvic radiotherapy

References

• Li L, Steinauer KK, Dirks AJ, Husbeck B, Gibbs I, Knox SJ. Radiation-induced cyclooxygenase 2 up-regulation is dependent on redox status in prostate cancer cells. Radiat Res 2003; 160: 617–21
   PubMed Web of Science ®Google Scholar
• Steinauer KK, Gibbs I, Ning S, French JN, Armstrong J, Knox SJ. Radiation induces upregulation of cyclooxygenase-2 (COX-2) protein in PC-3 cells. Int J Radiat Oncol Biol Phys 2000; 48: 325–8
   PubMed Web of Science ®Google Scholar
• Cohn SM, Schloemann S, Tessner T, Seibert K, Stenson WF. Crypt stem cell survival in the mouse intestinal epithelium is regulated by prostaglandins synthesized through cyclooxygenase-1. J Clin Invest 1997; 99: 1367–79
   PubMed Web of Science ®Google Scholar
• Keskek, M, Gocmen, E, Kilic, M, Gencturk, S, Can, B, Cengiz, M, et al. Increased expression of cyclooxygenase-2 (COX-2) in radiation-induced small bowel injury in rats. J Surg Res 2006; (in press).
   PubMed Web of Science ®Google Scholar
• Arslan G, Brunborg LA, Froyland L, Brun JG, Valen M, Berstad A. Effects of duodenal seal oil administration in patients with inflammatory bowel disease. Lipids 2002; 37: 935–40
   PubMed Web of Science ®Google Scholar
• Cole AT, Slater K, Sokal M, Hawkey CJ. In vivo rectal inflammatory mediator changes with radiotherapy to the pelvis. Gut 1993; 34: 1210–4
   PubMed Web of Science ®Google Scholar
• Lifshitz S, Savage JE, Taylor KA, Tewfik HH, Van Orden DE. Plasma prostaglandin levels in radiation-induced enteritis. Int J Radiat Oncol Biol Phys 1982; 8: 275–7
   PubMed Web of Science ®Google Scholar
• Hauer-Jensen M, Wang J, Denham JW. Bowel injury: Current and evolving management strategies. Semin Radiat Oncol 2003; 13: 357–71
   PubMed Web of Science ®Google Scholar
• McGough C, Baldwin C, Frost G, Andreyev HJ. Role of nutritional intervention in patients treated with radiotherapy for pelvic malignancy. Br J Cancer 2004; 90: 2278–87
   PubMed Web of Science ®Google Scholar
• Guren MG, Schneede J, Tveit KM, Ueland PM, Nexo E, Dueland S. Biochemical signs of impaired cobalamin status during and after radiotherapy for rectal cancer. Int J Radiat Oncol Biol Phys 2004; 60: 807–13
   PubMed Web of Science ®Google Scholar
• Guren MG, Tobiassen LB, Trygg KU, Drevon CA, Dueland S. Dietary intake and nutritional indicators are transiently compromised during radiotherapy for rectal cancer. Eur J Clin Nutr 2006; 60: 113–9
   PubMed Web of Science ®Google Scholar
• Fransson P, Tavelin B, Widmark A. Reliability and responsiveness of a prostate cancer questionnaire for radiotherapy-induced side effects. Support Care Cancer 2001; 9: 187–98
   PubMed Web of Science ®Google Scholar
• Hovdenak N, Karlsdottir A, Sorbye H, Dahl O. Profiles and time course of acute radiation toxicity symptoms during conformal radiotherapy for cancer of the prostate. Acta Oncol 2003; 42: 741–8
   PubMed Web of Science ®Google Scholar
• Hovdenak N, Fajardo LF, Hauer-Jensen M. Acute radiation proctitis: A sequential clinicopathologic study during pelvic radiotherapy. Int J Radiat Oncol Biol Phys 2000; 48: 1111–7
   PubMed Web of Science ®Google Scholar
• Lie O, Lambertsen G. Fatty acid composition of glycerophospholipids in seven tissues of cod (Gadus morhua), determined by combined high-performance liquid chromatography and gas chromatography. J Chromatogr 1991; 565: 119–29
   PubMed Web of Science ®Google Scholar
• Torstensen BE, Lie O, Froyland L. Lipid metabolism and tissue composition in Atlantic salmon (Salmo salar L.)–effects of capelin oil, palm oil, and oleic acid-enriched sunflower oil as dietary lipid sources. Lipids 2000; 35: 653–64
   PubMed Web of Science ®Google Scholar
• Espe M, Kiessling A, Lunestad B-T, Torrisen O, Rora A. Quality of cold smoked salmon collected in one French hypermarket during a period of 1 year. Food Science Technol 2004; 37: 627–38
   Google Scholar
• Hamre K, Næss T, Espe M, Holm J, Lie O. A formulated diet for Atlantic halibut larvae. Acriculture Nutrition 2001; 7: 123–32
   Web of Science ®Google Scholar
• Ton, H, Brandsnes, Dale, S, Holtlund, J, Skuibina, E, Schjonsby, H, et al. Improved assay for fecal calprotectin. Clin Chim Acta 2000;292:41–54.
   PubMed Web of Science ®Google Scholar
• Kristinsson J, Roseth A, Fagerhol MK, Aadland E, Schjonsby H, Bormer OP, et al. Fecal calprotectin concentration in patients with colorectal carcinoma. Dis Colon Rectum 1998; 41: 316–21
   PubMed Web of Science ®Google Scholar
• Larsen, A, Bronstein, IB, Dahl, O, Wentzel-Larsen, T, Kristoffersen, EK, Fagerhol, MK. Quantification of S100A12 (EN-RAGE) in blood varies with sampling method, calcium and heparin. Scand J Immunol 2006; (in press).
   Web of Science ®Google Scholar
• Karlsdottir A, Johannessen DC, Muren LP, Wentzel-Larsen T, Dahl O. Acute morbidity related to treatment volume during 3D-conformal radiation therapy for prostate cancer. Radiother Oncol 2004; 71: 43–53
   PubMed Web of Science ®Google Scholar
• Peeters ST, Heemsbergen WD, van Putten WL, Slot A, Tabak H, Mens JW, et al. Acute and late complications after radiotherapy for prostate cancer: Results of a multicenter randomized trial comparing 68 Gy to 78 Gy. Int J Radiat Oncol Biol Phys 2005; 61: 1019–34
   PubMed Web of Science ®Google Scholar
• Dahl O, Horn A, Mella O. Do acute side-effects during radiotherapy predict tumour response in rectal carcinoma?. Acta Oncol 1994; 33: 409–13
   PubMed Web of Science ®Google Scholar
• Jereczek-Fossa BA, Jassem J, Badzio A. Relationship between acute and late normal tissue injury after postoperative radiotherapy in endometrial cancer. Int J Radiat Oncol Biol Phys 2002; 52: 476–82
   PubMed Web of Science ®Google Scholar
• O'Brien PC, Franklin CI, Poulsen MG, Joseph DJ, Spry NS, Denham JW. Acute symptoms, not rectally administered sucralfate, predict for late radiation proctitis: Longer term follow-up of a phase III trial–Trans-Tasman Radiation Oncology Group. Int J Radiat Oncol Biol Phys 2002; 54: 442–9
   PubMed Web of Science ®Google Scholar
• Schultheiss TE, Lee WR, Hunt MA, Hanlon AL, Peter RS, Hanks GE. Late GI and GU complications in the treatment of prostate cancer. Int J Radiat Oncol Biol Phys 1997; 37: 3–11
   PubMed Web of Science ®Google Scholar
• Wang CJ, Leung SW, Chen HC, Sun LM, Fang FM, Huang EY, et al. The correlation of acute toxicity and late rectal injury in radiotherapy for cervical carcinoma: Evidence suggestive of consequential late effect (CQLE). Int J Radiat Oncol Biol Phys 1998; 40: 85–91
   PubMed Web of Science ®Google Scholar
• Khan AM, Birk JW, Anderson JC, Georgsson M, Park TL, Smith CJ, et al. A prospective randomized placebo-controlled double-blinded pilot study of misoprostol rectal suppositories in the prevention of acute and chronic radiation proctitis symptoms in prostate cancer patients. Am J Gastroenterol 2000; 95: 1961–6
   PubMed Web of Science ®Google Scholar
• Denham JW, Hauer-Jensen M. The radiotherapeutic injury-a complex 'wound'. Radiother Oncol 2002; 63: 129–45
   PubMed Web of Science ®Google Scholar
• Prasad KN, Cole WC, Kumar B, Che PK. Pros and cons of antioxidant use during radiation therapy. Cancer Treat Rev 2002; 28: 79–91
   PubMed Web of Science ®Google Scholar
• Crawford PA, Gordon JI. Microbial regulation of intestinal radiosensitivity. Proc Natl Acad Sci USA 2005; 102: 13254–9
   PubMed Web of Science ®Google Scholar
• Salminen E, Elomaa I, Minkkinen J, Vapaatalo H, Salminen S. Preservation of intestinal integrity during radiotherapy using live Lactobacillus acidophilus cultures. Clin Radiol 1988; 39: 435–7
   PubMed Web of Science ®Google Scholar
• Cengiz M, Akbulut S, Atahan IL, Grigsby PW. Acute phase response during radiotherapy. Int J Radiat Oncol Biol Phys 2001; 49: 1093–6
   PubMed Web of Science ®Google Scholar
• Larsen A, Hovdenak N, Karlsdottir A, Wentzel-Larsen T, Dahl O, Fagerhol MK. Faecal calprotectin and lactoferrin as markers of acute radiation proctitis: A pilot study of eight stool markers. Scand J Gastroenterol 2004; 39: 1113–8
   PubMed Web of Science ®Google Scholar
• Kane SV, Sandborn WJ, Rufo PA, Zholudev A, Boone J, Lyerly D, et al. Fecal lactoferrin is a sensitive and specific marker in identifying intestinal inflammation. Am J Gastroenterol 2003; 98: 1309–14
   PubMed Web of Science ®Google Scholar
• Roseth AG. Determination of faecal calprotectin, a novel marker of organic gastrointestinal disorders. Dig Liver Dis 2003; 35: 607–9
   PubMedGoogle Scholar